ZEPOSIA
ZEPOSIA
Approved
DIN Number
02506009
Drug Class
Human
Market Date
Nov 12, 2020
Company
HC
bristol-myers squibb canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02506009
AIG Number0262519001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AE02 OZANIMOD
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification90:04.16
Health Canada Classification
ACTIVE INGREDIENTS (2)
OZANIMOD (OZANIMOD HYDROCHLORIDE)Active
Strength: 0.23 MG
Monograph: OZANIMOD (OZANIMOD HYDROCHLORIDE)
OZANIMOD (OZANIMOD HYDROCHLORIDE)Active
Strength: 0.46 MG
Monograph: OZANIMOD (OZANIMOD HYDROCHLORIDE)